A mother of three was “shocked” to discover she was suffering from stage 4 bowel cancer after doctors initially diagnosed her ...

Discover how the FIT test is transforming colorectal cancer screening, reducing mortality rates and offering a more ...

Breakthroughs in laboratory and data science are increasing interest in blood tests to screen for cancer, with colorectal ...

Under the agreement, Sysmex will distribute and service in Canada Sentinel Diagnostics' SentiFit 270 and SentiFit 800 analyzers for fecal immunochemical testing.

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and ...

A1, a new biomarker, improves early detection of colorectal cancer with higher accuracy and less invasiveness.

A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method ...

DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical ...

In the present study, test accuracy of one of the most commonly used FITs was evaluated in a large cohort of asymptomatic, high-risk individuals undergoing colonoscopy surveillance. It was found ...

People aged 50 and above in England will be eligible for routine bowel cancer screening in 2025 as the age for tests lowered, a minister has confirmed. The NHS committed to lowering the age of ...

Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim ...

Fecal Immunochemical Diagnostic Test (FIT) Market The FIT market is growing due to increased awareness and adoption of non-invasive colorectal cancer screening options. WILMINGTON, DE, UNITED STATES,.